Eye Kare Kilitch Limited

Produces eye care products for various eye conditions, with a focus on Ophthalmology.

2009 | Mumbai, Maharashtra (India) | Active
Last Updated:

Eye Kare Kilitch Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 5.00 Cr
  • Company Age 15 Year, 2 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth 73.23%
  • Ebitda 73.23%
  • Net Worth -11.88%
  • Total Assets -25.32%

About Eye Kare Kilitch

Eye Kare Kilitch Limited (EKKL) is a Public Limited Indian Non-Government Company incorporated in India on 31 December 2009 and has a history of 15 years and two months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

Paresh Mehta, Neha Mehta, Mukesh Shah, and Three other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    eyekarekilitch.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24297MH2009PLC198224

  • Company No.

    198224

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    31 Dec 2009

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Eye Kare Kilitch?

Executive Team (1)

NameDesignationAppointment DateStatus
Paresh Mehta Country flag representing In Managing Director31-Dec-2009Current

Board Members (5)

NameDesignationAppointment DateStatus
Mukesh Agashiwala Country flag representing In Director 01-Dec-2014Current
Divya Mehta Country flag representing In Director 14-May-2013Current
Neha Mehta Country flag representing In Director 14-May-2013Current
Mukesh Shah Country flag representing In Director 30-Jun-2010Current
Pradyumna Pande Country flag representing In Director 27-May-2014Current

Financial Performance of Eye Kare Kilitch.

Eye Kare Kilitch Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 73.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.88%.

Eye Kare Kilitch revenue growth over time
Eye Kare Kilitch profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-25.32%
Profit or Loss
73.23%
Net Worth
-11.88%
EBITDA
73.23%

What is the Ownership and Shareholding Structure of Eye Kare Kilitch?

In 2023, Eye Kare Kilitch had a promoter holding of 93.30% and a public holding of 6.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Eye Kare Kilitch?

Eye Kare Kilitch has a workforce of 55 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Eye Kare Kilitch Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eye Kare Kilitch, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eye Kare Kilitch's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Eye Kare Kilitch

Recent activity within the organization

  • Annual General Meeting

    Eye Kare Kilitch Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Eye Kare Kilitch Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Mukesh Manmohandas Agashiwala was appointed as a Director was appointed as a Director on 01 Dec 2014 & has been associated with this company since 10 years 3 months .

  • Director Appointment

    Pradyumna Upendra Pande was appointed as a Director was appointed as a Director on 27 May 2014 & has been associated with this company since 10 years 9 months .

  • Director Appointment

    Neha Paresh Mehta was appointed as a Director was appointed as a Director on 14 May 2013 & has been associated with this company since 11 years 9 months .

  • Director Appointment

    Divya Paresh Mehta was appointed as a Director was appointed as a Director on 14 May 2013 & has been associated with this company since 11 years 9 months .

Frequently asked questions

  • What is the Incorporation or founding date of Eye Kare Kilitch Limited?

    Eye Kare Kilitch Limited was incorporated on 31 Dec 2009.

  • What is authorized share capital and paid-up capital of Eye Kare Kilitch Limited?

    The authorized share capital of Eye Kare Kilitch Limited is ₹ 10.00 Cr and paid-up capital is ₹ 5.00 Cr.

  • Who are the current board members & directors of Eye Kare Kilitch Limited?

    Currently 6 directors are associated with Eye Kare Kilitch Limited.

    • Paresh Prataprai Mehta
    • Neha Paresh Mehta
    • Mukesh Damji Shah
    • Divya Paresh Mehta
    • Mukesh Manmohandas Agashiwala
    • Pradyumna Upendra Pande

  • What is the registered address of Eye Kare Kilitch Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Eye Kare Kilitch Limited is 902-B Coliseum Co-Op Premises Soc. Ltd. Godrej Coliseum Off Eastern Express Highway, C Hunabhatti India, Mumbai, Maharashtra, 400022.

  • What is the corporate identification number (CIN) and company number of Eye Kare Kilitch Limited?

    The corporate identification number (CIN) of Eye Kare Kilitch Limited is U24297MH2009PLC198224 and the company number is 198224 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Eye Kare Kilitch Limited?

    The Official website of Eye Kare Kilitch Limited is https://www.eyekarekilitch.com

  • How many employees does Eye Kare Kilitch Limited currently have?

    As Per 2023 financial reports, 55 employees are currently employed by Eye Kare Kilitch Limited.

  • What change has been observed in the net worth of Eye Kare Kilitch Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Eye Kare Kilitch Limited has experienced an downturn of -11.88%.

  • When was the last Balance Sheet of Eye Kare Kilitch Limited filed with the ROC?

    The most recent Balance Sheet for Eye Kare Kilitch Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development